Cargando…
CK1α overexpression correlates with poor survival in colorectal cancer
BACKGROUND: Colorectal cancer (CRC) is the fourth leading cause of cancer related deaths worldwide and prognosis in advanced tumor stage still remains poor. Since CK1 isoforms have been reported to be deregulated in several tumor entities CK1 has emerged as a novel drug target in cancer therapy. In...
Autores principales: | Richter, Julia, Kretz, Anna-Laura, Lemke, Johannes, Fauler, Michael, Werner, Jens-Uwe, Paschke, Stephan, Leithäuser, Frank, Henne-Bruns, Doris, Hillenbrand, Andreas, Knippschild, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801892/ https://www.ncbi.nlm.nih.gov/pubmed/29409464 http://dx.doi.org/10.1186/s12885-018-4019-0 |
Ejemplares similares
-
Microtubules Depolymerization Caused by the CK1 Inhibitor IC261 May Be Not Mediated by CK1 Blockage
por: Stöter, Martin, et al.
Publicado: (2014) -
Should We Keep Walking along the Trail for Pancreatic Cancer Treatment? Revisiting TNF-Related Apoptosis-Inducing Ligand for Anticancer Therapy
por: Kretz, Anna-Laura, et al.
Publicado: (2018) -
TRAILblazing Strategies for Cancer Treatment
por: Kretz, Anna-Laura, et al.
Publicado: (2019) -
Endogenously Expressed IL-4Rα Promotes the Malignant Phenotype of Human Pancreatic Cancer In Vitro and In Vivo
por: Traub, Benno, et al.
Publicado: (2017) -
Evaluation of CDK9 Inhibition by Dinaciclib in Combination with Apoptosis Modulating izTRAIL for the Treatment of Colorectal Cancer
por: Shen, Xiao, et al.
Publicado: (2023)